Virtual reality therapy: The future of chronic pain management?Could virtual reality tools be effective in helping patients ‘unlearn’ their chronic pain? Professor Christopher Eccleston from the Share XVirtual reality therapy: The future of chronic pain management?https://pharmaphorum.com/views-and-analysis/virtual-reality-therapy-the-future-of-chronic-pain-management/
Virtual GP clinics – are they accessible as they need to be?As the the pandemic accelerates a move towards remote doctors appointments, work still needs to be done to Share XVirtual GP clinics – are they accessible as they need to be?https://pharmaphorum.com/digital/virtual-clinics-are-they-accessible-as-they-need-to-be/
How digital pathways are changing healthcareAs demonstrated throughout COVID, digital health is no longer experimental. Digital technologies are proving their value by allowing Share XHow digital pathways are changing healthcarehttps://pharmaphorum.com/digital/how-digital-pathways-are-changing-healthcare/
Deep Dive: Oncology 2021This has probably been the toughest year for oncology researchers in memory. As this issue’s contributors discuss, funding Share XDeep Dive: Oncology 2021https://pharmaphorum.com/views-analysis-oncology/deep-dive-oncology-2021/
Blockchain: Ready to revolutionise medicinal cannabis research?Robert Galarza outlines how blockchain technology can be utilised to verify, validate and standardise the efficacy of medical Share XBlockchain: Ready to revolutionise medicinal cannabis research?https://pharmaphorum.com/views-and-analysis/blockchain-ready-to-revolutionise-medicinal-cannabis-research/
Health Innovators: Fredrik Debong, Hi.HealthIn this episode of our Health Innovators series, Paul Tunnah is joined by tech entrepreneur Fredrik Debong. Fredrik Share XHealth Innovators: Fredrik Debong, Hi.Healthhttps://pharmaphorum.com/video/health-innovators-fredrik-debong-hi-health/
Pandemic paves way for innovative hybrid healthcareWhile the heroic abilities of the NHS have been on display throughout the COVID-19 pandemic, the last year Share XPandemic paves way for innovative hybrid healthcarehttps://pharmaphorum.com/views-and-analysis/playing-catch-up-the-evolution-of-pharma-marketing/
Transforming pharma R&D with a scientist-centric approach to AI & automationAs biopharmaceutical products have become increasingly complex, both in design and in regulatory requirements, we need a new Share XTransforming pharma R&D with a scientist-centric approach to AI & automationhttps://pharmaphorum.com/views-and-analysis/transforming-pharma-rd-with-a-scientist-centric-approach-to-ai-automation/
A roadmap for adopting New ScienceThe pandemic’s disruption galvanised the biopharma industry into unprecedented action, demonstrating what’s possible when the global scientific community Share XA roadmap for adopting New Sciencehttps://pharmaphorum.com/market-access-2/a-roadmap-for-adopting-new-science/
